📢 Expressions of Interest are now open for the Early Career Women in STEMM Grant & Paper Writing Workshop (ECWW2026), url.au.m.mimecastprotect.com/s/4DD5CQnMOq... #WomenInSTEMM #EarlyCareerResearchers #ResearchWriting #GrantWriting #AcademicDevelopment #STEMM #ResearchCareer

www.sydney.edu.au/medicine-hea... 🎉 Join the 2026 Early Career Women in STEMM Grant & Paper Writing Workshop! ✍️🌟 📅 28–30 Sept 2026 📍 Learning Studio 225, Susan Wakil Building, The University of Sydney Scientific writing, mentoring & career development. Save the date registrations coming soon!

Expanding the power of drugs used to treat liquid malignancies into solid tumours. We screened an epigenetic compound library against cell lines models of ovarian clear cell carcinoma. The BTK inhibitor ibrutinib shows promise #ovariancancer #ibrutinib 🧪 onlinelibrary.wiley.com/doi/epdf/10....

Comprehensive review out in December's Biomedicine & Pharmacotherapy from postdoc in my group @amanialghalayini.bsky.social - #GynaecologicalCancer #DrugRepurposing #GynaeCancers #OvarianCancer #EndometrialCancer #Organoids #3Rs #ClinicalTrials & more!! 🧪 www.sciencedirect.com/science/arti...

Fantastic talk by Prof Alan D’Andrea (Dana-Farber Cancer Institute, Harvard Medical School) showing how the EWS-FLI1 fusion disrupts POLQ splicing and impairs the MMEJ DNA repair pathway in Ewing sarcoma @Australian Cell Cycle, DNA Repair, and Telomere Meeting 2025 #ACDTM25#CancerResearch

True cancer care must go beyond removing tumours. It must address the lasting scars, the fear of recurrence, and the need for ongoing support. Because survivorship is not just about living longer it is about living well. A powerful reminder from Prof. Bogda Koczwara at the #NSWcancersummit2025

Early-career researcher @amanialghalayini.bsky.social from our group presenting her research in Canberra this week at the #ANZGOG2025ASM on in silico modelling & #DrugRepurposing to discover new ways to treat #ARID1A mutant #OvarianCancer. #ChromatinRemodelling #OvarianClearCellCarcinoma 🧪

A pleasure to share the A Team's collaboration with researchers in the MRFF Drug Repurposing for Ovarian Cancer study at #Surv25 poster session.

Great talk from invited speaker Prof @djmarsh24.bsky.social at #ANZGOG2025 on ovarian cancer and ARID1A-related drug discovery